These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35114677)

  • 1. What Should Be Responsible for Eryptosis in Chronic Kidney Disease?
    Li D; Zheng X; Zhang Y; Li X; Chen X; Yin Y; Hu J; Li J; Guo M; Wang X
    Kidney Blood Press Res; 2022; 47(6):375-390. PubMed ID: 35114677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eryptosis: a driver of anemia in chronic kidney disease.
    Bissinger R; Qadri SM; Artunc F
    Curr Opin Nephrol Hypertens; 2024 Mar; 33(2):220-225. PubMed ID: 37987655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eryptosis - the Neglected Cause of Anemia in End Stage Renal Disease.
    Lang F; Bissinger R; Abed M; Artunc F
    Kidney Blood Press Res; 2017; 42(4):749-760. PubMed ID: 29151105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uremia and Inadequate Oxygen Supply Induce Eryptosis and Intracellular Hypoxia in Red Blood Cells.
    Dias GF; Tozoni SS; Bohnen G; Grobe N; Rodrigues SD; Meireles T; Nakao LS; Pecoits-Filho R; Kotanko P; Moreno-Amaral AN
    Cell Physiol Biochem; 2021 Jul; 55(4):449-459. PubMed ID: 34259420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal anemia: from relative insufficiency of EPO to imbalance of erythropoiesis and eryptosis.
    Yuan M; Chen X; Ou R; Luo R; Fan W; Wang X; Guo Z
    Int Urol Nephrol; 2024 Jul; ():. PubMed ID: 38982020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Eryptosis in the Pathogenesis of Renal Anemia: Insights From Basic Research and Mathematical Modeling.
    Dias GF; Grobe N; Rogg S; Jörg DJ; Pecoits-Filho R; Moreno-Amaral AN; Kotanko P
    Front Cell Dev Biol; 2020; 8():598148. PubMed ID: 33363152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of eryptosis in patients with chronic kidney disease.
    Gok MG; Paydas S; Boral B; Onan E; Kaya B
    Int Urol Nephrol; 2022 Nov; 54(11):2919-2928. PubMed ID: 35469112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red Blood Cell Lifespan Shortening in Patients with Early-Stage Chronic Kidney Disease.
    Li JH; Luo JF; Jiang Y; Ma YJ; Ji YQ; Zhu GL; Zhou C; Chu HW; Zhang HD
    Kidney Blood Press Res; 2019; 44(5):1158-1165. PubMed ID: 31550724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockage of the Na-K-ATPase signaling-mediated oxidant amplification loop elongates red blood cell half-life and ameliorates uremic anemia induced by 5/6th PNx in C57BL/6 mice.
    Liu J; Chaudhry M; Bai F; Chuang J; Chaudhry H; Al-Astal AY; Nie Y; Sollars V; Sodhi K; Seligman P; Shapiro JI
    Am J Physiol Renal Physiol; 2022 Jun; 322(6):F655-F666. PubMed ID: 35435001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron Metabolism and Inflammatory Mediators in Patients with Renal Dysfunction.
    Matsuoka T; Abe M; Kobayashi H
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Induction of Eryptosis by Uremic Toxins and Inflammation Mediators in Healthy Red Blood Cells.
    Virzì GM; Mattiotti M; Clementi A; Milan Manani S; Battaglia GG; Ronco C; Zanella M
    J Clin Med; 2022 Sep; 11(18):. PubMed ID: 36142976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review.
    Hamza E; Metzinger L; Metzinger-Le Meuth V
    Cells; 2020 Sep; 9(9):. PubMed ID: 32899941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suicidal erythrocyte death in end-stage renal disease.
    Abed M; Artunc F; Alzoubi K; Honisch S; Baumann D; Föller M; Lang F
    J Mol Med (Berl); 2014 Aug; 92(8):871-9. PubMed ID: 24743961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron Metabolism in Chronic Kidney Disease Patients.
    Honda H; Hosaka N; Ganz T; Shibata T
    Contrib Nephrol; 2019; 198():103-111. PubMed ID: 30991401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia.
    Bonan NB; Steiner TM; Kuntsevich V; Virzì GM; Azevedo M; Nakao LS; Barreto FC; Ronco C; Thijssen S; Kotanko P; Pecoits-Filho R; Moreno-Amaral AN
    Blood Purif; 2016; 41(4):317-23. PubMed ID: 26848873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing Anemia across the Stages of Kidney Disease in Those Hyporesponsive to Erythropoiesis-Stimulating Agents.
    Weir MR
    Am J Nephrol; 2021; 52(6):450-466. PubMed ID: 34280923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eryptosis in Patients with Chronic Kidney Disease: A Possible Relationship with Oxidative Stress and Inflammatory Markers.
    Clementi A; Virzì GM; Milan Manani S; Battaglia GG; Ronco C; Zanella M
    J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicidal death of erythrocytes in cancer and its chemotherapy: A potential target in the treatment of tumor-associated anemia.
    Lang E; Bissinger R; Qadri SM; Lang F
    Int J Cancer; 2017 Oct; 141(8):1522-1528. PubMed ID: 28542880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Mechanisms and Pathophysiological Significance of Eryptosis.
    Alghareeb SA; Alfhili MA; Fatima S
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress and suicidal erythrocyte death.
    Lang F; Abed M; Lang E; Föller M
    Antioxid Redox Signal; 2014 Jul; 21(1):138-53. PubMed ID: 24359125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.